Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Pieris Pharmaceuticals Price to Book Ratio 1970-1969 | PVLA

Historical price to book ratio values for Pieris Pharmaceuticals (PVLA) over the last 10 years. The current price to book ratio for Pieris Pharmaceuticals as of December 20, 2024 is 0.97.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Pieris Pharmaceuticals Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-12-20 12.05 inf
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.016B $0.043B
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Swiftmerge Acquisition (ANNA) United States $0.042B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00